N※N

Probiotic Peptides Achieve 99% Reduction of Salmonella in Chickens

95

  //food-wine.news-articles.net/content/2025/11/19 .. ieve-99-reduction-of-salmonella-in-chickens.html
  Published in Food and Wine on Wednesday, November 19th 2025 at 21:29 GMT by Food & Wine

• 🞛 This publication is a summary or evaluation of another publication
• 🞛 This publication contains editorial commentary or bias from the source

2025-11-19 248 x 203 / 11152 Bytes

2025-11-19 247 x 204 / 8427 Bytes

2025-11-19 221 x 224 / 9690 Bytes

2025-11-19 226 x 223 / 6378 Bytes

Probiotic Peptides Offer a New Front in the Fight Against Salmonella in Poultry

Food‑and‑Wine’s recent coverage of a breakthrough study in the poultry industry underscores how science is turning to nature‑derived solutions to curb one of the most common food‑borne threats—Salmonella contamination. The research, published in the journal Frontiers in Microbiology (see the full paper via the “Read the study” link in the article), shows that a set of small proteins—probiotic peptides—derived from beneficial bacteria can dramatically reduce Salmonella levels in chickens. The findings have far‑reaching implications for producers, regulators, and consumers alike.

The Salmonella Problem in Poultry

Salmonella is a leading cause of foodborne illness worldwide, and poultry products rank among the top vectors for human infections. Each year, the Centers for Disease Control and Prevention estimates that more than 1.3 million people in the United States contract Salmonella, with a significant proportion linked to contaminated chicken or chicken products. Traditional control methods include stringent hygiene, vaccination of birds, and the use of antibiotics as growth promoters. However, the widespread use of antibiotics has led to escalating concerns about antimicrobial resistance, prompting regulators to tighten restrictions and prompting producers to seek alternative strategies.

The Study Design

Researchers from the University of Wisconsin–Madison’s Department of Animal Sciences, led by Dr. Sara H. Jones, conducted a controlled trial involving 1,200 broiler chickens divided into four groups. Two groups received conventional feed, while the other two received feed supplemented with either a standard probiotic blend (Lactobacillus acidophilus and Bifidobacterium bifidum) or a novel peptide‑enriched probiotic. The peptides in question—termed “SalmoPeps”—were isolated from a probiotic strain isolated from fermented kimchi and characterized for their antimicrobial activity against Salmonella enterica serovars Typhimurium and Enteritidis.

Throughout the 35‑day grow‑out period, the researchers monitored bird health, weight gain, feed conversion ratios, and—critically—Salmonella loads in the cecal contents and on carcasses at processing. The data were collected under USDA‑approved conditions and analyzed using mixed‑effects models to account for farm‑level variability.

Key Findings

1. Significant Reduction in Salmonella Load
   Chickens fed the peptide‑enriched probiotic exhibited a 2.3‑log10 reduction in Salmonella counts in the cecum compared with the control group. On carcasses, the reduction was 1.8‑log10. These figures represent a roughly 99% decrease in bacterial burden, a level that could translate into a meaningful drop in human illness rates.

2. No Adverse Effects on Growth Performance
   Importantly, the peptide‑treated birds displayed weight gain and feed conversion ratios comparable to the control groups, indicating that the supplement did not interfere with growth or feed efficiency—an essential consideration for producers.

3. Peptide Stability and Mode of Action
   Laboratory assays revealed that the peptides were stable across a broad pH range (4–9) and retained activity at temperatures up to 75 °C, suggesting that they can survive the feed manufacturing process. Mechanistic studies pointed to a dual action: direct bactericidal activity and interference with Salmonella’s flagellar motility, thereby reducing the pathogen’s ability to colonize the gut mucosa.

4. Synergy with Conventional Probiotics
   When combined with the standard probiotic blend, the peptides’ effect was amplified, indicating a potential synergistic relationship that could further enhance gut health and pathogen suppression.

Contextualizing the Findings

The article connects these findings to the broader narrative of reducing antibiotic use in livestock. In a linked “Probiotics and Poultry: A Safer Alternative” feature, the authors note that the FDA’s “One Health” initiative encourages the adoption of non‑antibiotic growth promoters that also safeguard public health. By offering a natural, microbiome‑friendly means to suppress Salmonella, probiotic peptides could become a cornerstone of integrated disease‑control programs.

Another useful reference in the article is a Food & Wine piece on “The Rise of Antimicrobial Peptides in Food Safety,” which explains how antimicrobial peptides (AMPs) have been investigated in dairy, seafood, and even plant-based foods. The authors highlight that, unlike traditional antibiotics, AMPs target bacterial membranes or signaling pathways, reducing the likelihood of resistance development. The current study adds poultry to this growing list of applications.

Industry Implications

• Regulatory Pathways
  Because the peptides are derived from a food‑grade probiotic strain, the regulatory hurdles may be less daunting than for novel synthetic compounds. However, the authors caution that comprehensive safety assessments, including potential allergenicity and residue analyses, will be necessary before market approval.

• Cost and Production
  While the initial cost of peptide synthesis or extraction can be higher than conventional feed additives, the authors argue that the long‑term benefits—reduced carcass contamination, lower recalls, and compliance with evolving antibiotic‑restriction policies—could offset the expense.

• Consumer Perception
  With consumers increasingly demanding “antibiotic‑free” and “naturally raised” labels, probiotic peptides could become a marketing asset, differentiating brands that prioritize both animal welfare and public health.

Future Directions

The article points to several avenues for further research:

1. Long‑Term Field Trials
   Expanding studies to commercial farms across diverse geographic regions to confirm efficacy under real‑world conditions.

2. Mechanistic Deep‑Dive
   Employing omics technologies (metagenomics, transcriptomics) to unravel how peptides reshape the gut microbiota and modulate host immunity.

3. Combination Therapies
   Exploring synergy with other natural antimicrobials—such as essential oils or plant extracts—to develop multi‑modal control strategies.

4. Human Health Impact Assessment
   Modelling the potential reduction in Salmonella‑associated illness at the population level, thereby guiding policy decisions.

Takeaway

The Food & Wine article paints a hopeful picture: a science‑backed, low‑cost, and animal‑friendly tool that could markedly reduce the prevalence of Salmonella in poultry. By harnessing the power of probiotic peptides, the industry may finally have a reliable, antibiotic‑free strategy that protects both chickens and consumers. As the research moves from the lab to the feed mill, stakeholders across the supply chain—from farmers and feed manufacturers to regulators and diners—will be watching closely. The promise is clear: safer poultry, fewer foodborne outbreaks, and a step forward in the global battle against antimicrobial resistance.